SEDANA Share Price Performance
SEK 0
-11.46 (-100.00%)
Price SEK 0
Fair ValueSEK 18.00
Share Pricen/a
Narrative Update • Jun 17
Sedana Medical AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
SEDANA Community Narratives
AN
Fair Value
·Fair Value SEK 18 51.0% undervalued intrinsic discount
US Entry And European Sales Will Expand Market Opportunity
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
US Entry And European Sales Will Expand Market Opportunity
Sedana Medical is trying to turn a Europe-focused niche product into a much bigger business by breaking into the U.S. and expanding use in children. The upside rests on smoother approvals, strong hospital uptake, and cost improvements—while delays, tighter hospital budgets, and tougher competition could quickly squeeze growth and profitability.Read more
AN
SEK 18
51.0% undervalued intrinsic discount
Fair Value
Profit Margin
6.02%
Future PE
95.39x
Price in 2029
SEK 21.17
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
SEDANA: Early Access Milestone And 2026 NDA Filing Will Support Upside
Fair Value: SEK 18 51.0% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sedana Medical AB (publ) Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 17, 2026
- -0.40
- 71.28%
- -20.15%
- 0%
About SEDANA
- Founded
- 1999
- Employees
- 116
- CEO
- WebsiteView website
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.
